BackDalian BIO-CHEM Company Limited Overview

Dalian BIO-CHEM Company Limited Receivables

Dalian BIO-CHEM Company Limited's receivables is $280M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$283.16M
↓ 33.62% YoYΔ $-143.41M vs prior year quarter

Peer trimmed avg / median

Loading

Dalian BIO-CHEM Company Limited Receivables History

Loading

Dalian BIO-CHEM Company Limited vs. peers: Receivables Comparison

Loading

Dalian BIO-CHEM Company Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Dalian BIO-CHEM Company Limited (603360.SS) FAQ

As of the most recent data (September 2026), 603360.SS shows a receivables of $280M. That compares with $430M in the prior-year period — down 33.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603360.SS's receivables is now $280M (was $430M) — a 33.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dalian BIO-CHEM Company Limited is outperforming or lagging.

Tracking 603360.SS's receivables over time shows whether Dalian BIO-CHEM Company Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $280M That compares with $430M in the prior-year period — down 33.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Dalian BIO-CHEM Company Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $280M) with ownership activity and broader fundamentals.